Evista


Also found in: Medical, Wikipedia.

E•vis•ta

(ɪˈvɪs tə) Trademark.
a brand of raloxifene.
References in periodicals archive ?
The USPSTF said there is a "moderate benefit" of medications such as tamoxifen, raloxifene (Evista), or aromatase inhibitors for reducing the risk of invasive estrogen receptor (ER)-positive breast cancer in women at increased risk for breast cancer.
Among those expiring in 2017 are Avandia, Evista, Rhinoccort, Prozac Weekly, Sequel SR, Novolog, Biaxin XL, Victoza, Effexor SR and Ventolin HFA.
The company said the US Food & Drug Administration (USFDA) approved Raloxifene hydrochloride tablets in 60 mg, is the therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets.
The current ones, such as tamoxifen and raloxifene (Evista), don't prevent ER--breast cancer.
The association also announced four additions to its board: Luis Padilla of Re/Max Oceanside Realty in Miami; Danny Hernandez of EVista Resources Realty in Kissimmee, Fla; David Acosta of David Acosta Group in El Paso, Texas; and Pamela Valenciano of Solutions Real Estate in Carlsbad, Calif.
When raloxifene made by Eli Lilly under the trade name of Evista entered the market in 1997, its global sales value in the first year reached up to 285 million, making it the second most successful product of Eli Lilly.
patent expirations for Cymbalta (-40% to $287 million) and Evista (-55% to $66.8 million) continue to negatively impact results.
When it comes to generics, products which are no longer exclusive include Eli Lilly's Cymbalta and Evista. AstraZeneca's Nexium may see generics as of May 2014.
Raloxifene (Evista) slows bone thinning and may slightly increase bone thickness.
Prevention is an important tool in the fight against breast cancer, and two drugs--tamoxifen (Nolvadex) and raloxifene (Evista)--are currently first-line weapons in that war.